{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:21:21Z","timestamp":1781011281190,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.phymed.2021.153899","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T11:45:22Z","timestamp":1640864722000},"page":"153899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Combined therapy of Xiaoer Feire Kechuan oral liquid and azithromycin for mycoplasma Pneumoniae pneumonia in children: A systematic review &amp; meta-analysis"],"prefix":"10.1016","volume":"96","author":[{"given":"Yingying","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2021.153899_bib0001","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1186\/s12879-021-06508-7","article-title":"Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis","volume":"21","author":"Ahn","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.phymed.2021.153899_bib0002","first-page":"144","article-title":"Mycoplasma pneumoniae Carriage With De Novo Macrolide-Resistance and Breakthrough Pneumonia","author":"Alishlash","year":"2019","journal-title":"Pediatr"},{"key":"10.1016\/j.phymed.2021.153899_bib0003","first-page":"18757","article-title":"Observation on the curative effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of Mycoplasma pneumoniae pneumonia","volume":"4","author":"Bai","year":"2017","journal-title":"Elec. J. Clin. Med. Lit."},{"key":"10.1016\/j.phymed.2021.153899_bib0004","series-title":"Efficacy of Xiaoerfeirekechuan Oral Liquid combined With Azithromycin in the Treatment of Children With Mycoplasma pneumoniae Pneumonia","first-page":"379","author":"Cai","year":"2018"},{"key":"10.1016\/j.phymed.2021.153899_bib0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/crj.12379","article-title":"Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance","volume":"11","author":"Cao","year":"2017","journal-title":"Clin. Resp. J."},{"key":"10.1016\/j.phymed.2021.153899_bib0006","first-page":"896","article-title":"Clinical observation on sequential treatment of children's mycoplasma pneumonia by xiaoer feire kechuan oral liquid and azithromycin","volume":"13","author":"Chen","year":"2011","journal-title":"Zhejiang Clin. Med. J."},{"key":"10.1016\/j.phymed.2021.153899_bib0007","first-page":"297","article-title":"To observe the curative effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of children with Mycoplasma pneumoniae pneumonia","volume":"29","author":"Ding","year":"2019","journal-title":"China Health Care Nutr"},{"key":"10.1016\/j.phymed.2021.153899_bib0008","first-page":"112","article-title":"Effect of azithromycin combined with pediatric feike kechuan oral liquid on mycoplasma pneumonia","volume":"11","author":"Dong","year":"2020","journal-title":"China Health Stand. Manag."},{"key":"10.1016\/j.phymed.2021.153899_bib0009","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jcpt.12855","article-title":"Comparative efficacy of Chinese herbal injections combined with azithromycin for mycoplasma pneumonia in children: a Bayesian network meta-analysis of randomized controlled trials","volume":"44","author":"Duan","year":"2019","journal-title":"J. Clin. Pharm. Therap."},{"key":"10.1016\/j.phymed.2021.153899_bib0010","first-page":"141","article-title":"Evaluation of the effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of children with Mycoplasma pneumoniae pneumonia","volume":"17","author":"Fang","year":"2019","journal-title":"Cont. Med. Symp."},{"key":"10.1016\/j.phymed.2021.153899_bib0011","first-page":"153","article-title":"Study on the effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of children with Mycoplasma pneumoniae pneumonia","author":"Gao","year":"2018","journal-title":"Bao Jian Wen Hui"},{"key":"10.1016\/j.phymed.2021.153899_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8139040","article-title":"Ameliorative Effects of Infantile Feire Kechuan Oral Solution on Mycoplasma Pneumoniae Pneumonia in Infant Mouse and Rat Models","volume":"2018","author":"Guo","year":"2018","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.phymed.2021.153899_bib0013","first-page":"483","article-title":"Effect of azithromycin combined with infantile feirekechuan oral solution for mycoplasma pneumonia in children","volume":"33","author":"Han","year":"2016","journal-title":"J Xinxiang Med Univ"},{"key":"10.1016\/j.phymed.2021.153899_bib0014","first-page":"18","article-title":"Simultaneuos determination of two main component of Xiao'er Feire Kechuan Granules by \u0f32P-HPLC","volume":"38","author":"Hao","year":"2017","journal-title":"J. Jilin Med. Univ."},{"issue":"Suppl 2","key":"10.1016\/j.phymed.2021.153899_bib0015","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.phymed.2021.153899_bib0016","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2021.153899_bib0017","first-page":"190","article-title":"Analysis of the curative effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of children with Mycoplasma pneumoniae pneumonia","volume":"10","author":"Jin","year":"2016","journal-title":"Chinese J. Mod. Drug Appl."},{"key":"10.1016\/j.phymed.2021.153899_bib0018","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1542\/pir.2018-0016","article-title":"Mycoplasma Pneumonia in Children and Adolescents","volume":"41","author":"Krafft","year":"2020","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.phymed.2021.153899_bib0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ijmr.IJMR_1582_16","article-title":"Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections","volume":"147","author":"Kumar","year":"2018","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.phymed.2021.153899_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cid\/ciy419","article-title":"Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia","volume":"68","author":"Kutty","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.phymed.2021.153899_bib0021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","article-title":"Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"16","author":"Lee","year":"2018","journal-title":"Exp. Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.phymed.2021.153899_bib0022","first-page":"151","article-title":"Effect of infantile feire kechuan oral solution combined with azithromycin in treatment of mycoplasma pneumonia in children","volume":"32","author":"Li","year":"2019","journal-title":"Infect. Dis. Inf."},{"key":"10.1016\/j.phymed.2021.153899_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2346583","article-title":"Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: a Systematic Review and Meta-Analysis of Efficacy and Safety","volume":"2019","author":"Li","year":"2019","journal-title":"Evidence-based complementary and alternative medicine: eCAM"},{"key":"10.1016\/j.phymed.2021.153899_bib0025","first-page":"3267","article-title":"Effects of xiaoer feire kechuan oral liquid combined with azithromycin on pulmonary function and inflammatory factors in children with mycoplasma pneumonia","volume":"19","author":"Lin","year":"2019","journal-title":"Progr. Mod. Biomed."},{"key":"10.1016\/j.phymed.2021.153899_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.678631","article-title":"Chinese Herbal Medicine for the Treatment of Children and Adolescents With Refractory Mycoplasma Pneumoniae Pneumonia: a Systematic Review and a Meta-Analysis","volume":"12","author":"Ling","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.phymed.2021.153899_bib0027","first-page":"77","article-title":"Analysis of the curative effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of mycoplasmal pneumonia","volume":"36","author":"Liu","year":"2017","journal-title":"Nei Mongol J. Trad. Chinese Med."},{"key":"10.1016\/j.phymed.2021.153899_bib0028","first-page":"115","article-title":"Analysis of the curative effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of children with Mycoplasma pneumoniae pneumonia","volume":"17","author":"Liu","year":"2017","journal-title":"World Lat. Med. Inf."},{"key":"10.1016\/j.phymed.2021.153899_bib0029","first-page":"133","article-title":"Effect of Xiaoerfeirekechuan Oral Liquid and Azithromycin on Mycoplasma Pneumoniae Pneumonia","volume":"14","author":"Luan","year":"2020","journal-title":"Chinese J. Mod. Drug Appl."},{"key":"10.1016\/j.phymed.2021.153899_bib0030","first-page":"407","article-title":"Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy","volume":"17","author":"Lung","year":"2011","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.phymed.2021.153899_bib0031","first-page":"589","article-title":"Efficacy of Xiaoer-feire-kechuan oral solution in the treatment of Mycoplasma pneumoniae infection and its effect on serum inflammatory factors in children","volume":"28","author":"Luo","year":"2017","journal-title":"Hainan Med. J."},{"key":"10.1016\/j.phymed.2021.153899_bib0032","first-page":"701","article-title":"Observation on therapeutic effect of oral liquid of cough and asthma for children with lung heat combined with antibiotics on mycoplasma pneumonia in children","volume":"46","author":"Ma","year":"2018","journal-title":"Chinese Youjiang Med. J."},{"key":"10.1016\/j.phymed.2021.153899_bib0033","first-page":"1197","article-title":"Clinical observation on the treatment of 45 children with mycoplasma pneumonia pneumonia by azithromycin sequential therapy and pediatric feire kechuan oral liquid","volume":"16","author":"Mei","year":"2016","journal-title":"Chinese Rem. Clin."},{"key":"10.1016\/j.phymed.2021.153899_bib0034","first-page":"1517","article-title":"Observation on the effect of xiao'er feire kechuan oral solution with azithromyci on mycoplasma pneumoniae pneumonia","volume":"11","author":"Meng","year":"2016","journal-title":"World Chinese Med"},{"key":"10.1016\/j.phymed.2021.153899_bib0035","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/INF.0000000000002171","article-title":"The Art and Science of Diagnosing Mycoplasma pneumoniae Infection","volume":"37","author":"Meyer Sauteur","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.phymed.2021.153899_bib0036","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2021.153899_bib0037","first-page":"6","article-title":"Guidelines for diagnosis and treatment of community-acquired pneumonia in Children (2019 version)","volume":"12","author":"Ni","year":"2019","journal-title":"Chinese J. Clin. Infect. Dis."},{"key":"10.1016\/j.phymed.2021.153899_bib0038","first-page":"777","article-title":"130 cases of children's mycoplasma pneumonia treated by xiaoerfeire kechuan oral liquid combined with azithromycin","author":"Pang","year":"2007","journal-title":"Shaanxi J. Trad. Chinese Med."},{"key":"10.1016\/j.phymed.2021.153899_bib0039","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/BOR.0000000000000494","article-title":"Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis","volume":"30","author":"Poddighe","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.phymed.2021.153899_bib0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jmii.2019.04.011","article-title":"Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy","volume":"53","author":"Poddighe","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.phymed.2021.153899_bib0041","first-page":"71","article-title":"The effect of a widely used Chinese traditional medicinal oral liquid combined with budesonide on Th17 cells in infants with respiratory syncytial virus pneumonia and its clinical efficacy","volume":"10","author":"Qiu","year":"2020","journal-title":"Chinese J. Viral Dis."},{"key":"10.1016\/j.phymed.2021.153899_bib0042","doi-asserted-by":"crossref","first-page":"156","DOI":"10.23736\/S0026-4946.16.04866-0","article-title":"Diagnosis and treatment of Mycoplasma pneumoniae in children","volume":"69","author":"Rogozinski","year":"2017","journal-title":"Minerva Pediatr."},{"key":"10.1016\/j.phymed.2021.153899_bib0043","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cid\/ciy421","article-title":"Mycoplasma pneumoniae as a Cause of Community-Acquired Pneumonia in Children","volume":"68","author":"Shah","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.phymed.2021.153899_bib0044","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2021.153899_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462021","article-title":"A global profiling strategy using comprehensive two-dimensional liquid chromatography coupled with dual-mass spectrometry platforms: chemical analysis of a multi-herb Chinese medicine formula as a case study","volume":"1642","author":"Shang","year":"2021","journal-title":"J. chromatogr. A"},{"key":"10.1016\/j.phymed.2021.153899_bib0046","first-page":"134","article-title":"Observation on the curative effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of mycoplasma pneumonia in children","volume":"9","author":"Song","year":"2019","journal-title":"J. Front. Med."},{"key":"10.1016\/j.phymed.2021.153899_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109900","article-title":"Data mining and systematic pharmacology to reveal the mechanisms of traditional Chinese medicine in Mycoplasma pneumoniae pneumonia treatment","volume":"125","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2021.153899_bib0048","first-page":"138","article-title":"Xiaoer feire kechuan oral liquid and azithromycin in the treatment of children with mycoplasma pneumoniae pneumonia. China Cont","volume":"11","author":"Tan","year":"2019","journal-title":"Med. Educ."},{"key":"10.1016\/j.phymed.2021.153899_bib0049","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the Respiratory Tract and Beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.phymed.2021.153899_bib0050","first-page":"37","article-title":"Determination of Laetrile in Infantile Feirekechuan oral liquid by HPLC","volume":"8","author":"Wang","year":"2015","journal-title":"Chinese J. Clin. Rat. Drug Use"},{"key":"10.1016\/j.phymed.2021.153899_bib0051","doi-asserted-by":"crossref","first-page":"106","DOI":"10.23919\/j.cc.2019.05.009","article-title":"Analysis of the clinical effect and short-term recurrence of infantile mycoplasma pneumonia treated with pediatric feire kechuan oral liquid combined with azithromycin","volume":"35","author":"Wang","year":"2019","journal-title":"Chinese Commun. Doct."},{"key":"10.1016\/j.phymed.2021.153899_bib0052","first-page":"266","article-title":"Evaluation of the effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of children with mycoplasma pneumoniae pneumonia","author":"Wang","year":"2019","journal-title":"Ren. Doct."},{"key":"10.1016\/j.phymed.2021.153899_bib0053","doi-asserted-by":"crossref","first-page":"e16070","DOI":"10.1097\/MD.0000000000016070","article-title":"In vitro susceptibility test of Xiao'er Feire Kechuan Oral Solution to Mycoplasma pneumoniae","volume":"98","author":"Wei","year":"2019","journal-title":"Med."},{"key":"10.1016\/j.phymed.2021.153899_bib0054","first-page":"197","article-title":"Observation on the curative effect of Xiaoerfeirekechuan oral liquid combined with azithromycin in the treatment of Mycoplasma pneumoniae pneumonia","volume":"6","author":"Xiong","year":"2018","journal-title":"Cardiovasc Dis Electr. J. Integr. Tradit. Chinese West. Med."},{"key":"10.1016\/j.phymed.2021.153899_bib0055","first-page":"102","article-title":"Xiaoer feire kechuan oral liquid and azithromycin injection in the treatment of pediatric mycoplasma pneumoniae infection for 25 cases","volume":"14","author":"Xu","year":"2016","journal-title":"Chinese Med. Mod. Dist. Educ. China"},{"key":"10.1016\/j.phymed.2021.153899_bib0056","first-page":"464","article-title":"Efficacy and Mechanism of Xiaoer Feirre Kechuan Oral liquid combined with Western Medicine in the treatment of bronchopneumonia in Children","volume":"44","author":"Yang","year":"2021","journal-title":"J. Chinese Med. Mater."},{"key":"10.1016\/j.phymed.2021.153899_bib0057","first-page":"172","article-title":"Clinical study of azithromycin combined with Xiaoerfeirekechuan oral liquid in the treatment of children with mycoplasma pneumonia","volume":"6","author":"Yang","year":"2018","journal-title":"Cardiovasc. Dis. Electr. J. Integr. Trad. Chinese West. Med."},{"key":"10.1016\/j.phymed.2021.153899_bib0058","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmii.2018.09.009","article-title":"Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and\/or delayed treatment matter?","volume":"52","author":"Yang","year":"2019","journal-title":"J. microbiol. Immunol. Infect."},{"key":"10.1016\/j.phymed.2021.153899_bib0059","first-page":"111","article-title":"Therapeutic effects of children feire kechuan oral liquid combined with antibiotics on child patients with mycoplasma pneumonia","volume":"15","author":"Yang","year":"2020","journal-title":"China J. Pharmaceut. Econ."},{"key":"10.1016\/j.phymed.2021.153899_bib0060","first-page":"121","article-title":"Xiaoer feirekechuan oral solution combined with azithromycin for treating pediatric Mycoplasmal pneumonia in 43 cases","volume":"25","author":"Yu","year":"2016","journal-title":"China Pharmaceut"},{"key":"10.1016\/j.phymed.2021.153899_bib0061","first-page":"94","article-title":"Clinical observation of azithromycin combined with Xiaoerfeirekechuan oral liquid in the treatment of mycoplasma pneumonia in children","volume":"39","author":"Zhu","year":"2019","journal-title":"Clin. Med."},{"key":"10.1016\/j.phymed.2021.153899_bib0062","first-page":"441","article-title":"Observation on the curative effect of azithromycin in treatment of mycoplasma pneumonia in children with infantile Feirekechuan oral liquid","volume":"38","author":"Zhu","year":"2017","journal-title":"Jilin Med. J."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321004396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321004396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:33:46Z","timestamp":1760553226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321004396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":61,"alternative-id":["S0944711321004396"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153899","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined therapy of Xiaoer Feire Kechuan oral liquid and azithromycin for mycoplasma Pneumoniae pneumonia in children: A systematic review & meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153899"}}